Ahnn S., Anderson S.J. (1998): Sample size determination in complex clinical trials comparing more than two groups for survival endpoints. Statistics in Medicine 17(21): 2525–2534.10.1002/(SICI)1097-0258(19981115)17:21<2525::AID-SIM936>3.0.CO;2-E
Altman D.G. (1980): Statistics and ethics in medical research: III How large a sample? British Medical Journal, 281(6251): 1336.10.1136/bmj.281.6251.1336
Castellini G., Gianola S., Bonovas S., Moja L. (2016): Improving power and sample size calculation in rehabilitation trial reports: A methodological assessment. Archives of Physical Medicine and Rehabilitation 97(7): 1195–201.10.1016/j.apmr.2016.02.013
Charles P., Giraudeau B., Dechartres A., Baron G., Ravaud P. (2009): Re-porting of sample size calculation in randomised controlled trials. British Medical Journal.10.1136/bmj.b1732
Copsey B., Thompson J. Y., Vadher K., Ali U., Dutton S. J., Fitzpatric R., Lamb S. E., Cook J. A, (2018): Sample size calculations are poorly conducted and reported in many randomized trials of hip and knee osteoarthritis: results of a systematic review. Journal of Clinical Epidemiology 104: 52—61.10.1016/j.jclinepi.2018.08.013
Khan I., Sarker S., Hackshaw A. (2012): Smaller sample sizes for phase II trials based on exact tests with actual error rates by trading their nominal levels of significance and power. British Journal of Cancer 107(11): 1801–1809.10.1038/bjc.2012.444
Machin D., Campbell M., Fayers P., Pinol A. (1997a): Comparing paired groups for binary, ordered categorical and continuous outcomes. Sample Size Tables for Clinical Studies, 2nd edn. Oxford: Blackwell Science.
Machin D., Campbell M.J., Tan S.B., Tan S.H. (1997b): Comparing paired groups for binary, ordered categorical and continuous outcomes. Sample Size Tables for Clinical Studies, 3rd edn. pages 67–83.
Moussa M.A. (1988): Planning the size of survival time clinical trials with allowance for stratification. Statistics in Medicine, 7(5):559–569.10.1002/sim.47800705033387715
Sargent D.J. Taylor J.M. (2009): Current issues in oncology drug development, with a focus on phase II trials. Journal of Biopharmaceutical Statistics 19(3): 556–562.10.1080/10543400902802474411207619384696
Shahravan A., Haghdoost A., Rad M., Hashemipoor M., Shari M. (2014): Sample size calculation of clinical trials published in two leading endodontic journals. Iranian Endodontic Journal 9(1): 56–60.
Suresh K., Chandrashekara S. (2015): Sample size estimation and power analysis for clinical research studies. Journal of Human Reproductive Sciences 8(3): 186.10.4103/0974-1208.165154
Wang S.-J., Hung H., O’Neill R.T. (2006): Adapting the sample size planning of a phase III trial based on phase II data. Pharmaceutical Statistics 5(2): 85–97.10.1002/pst.217